In this study we demonstrate that inhibition of activated STAT3 by GL can decrease the viability of docetaxel-resistant and patient-derived spheres retaining stemness characteristics, indicating that this is a promising approach to target the cancer stem cell niche in PCa. The gene discussed is STAT3; the disease is posterior cortical atrophy.